| # | Filing Date | Period End Date | Type | Report Link | 
|---|---|---|---|---|
| No Data found | ||||
| # | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating | 
|---|
 
																	Massachusetts' average revenue per dispensary dropped to $362k/month, down 8% year-over-year, in New Mexico sales went down...
 
																	While Schwazze's issue may seem minor compared to past scandals, it serves as a reminder of how easily financial mistakes c...
 
																	
 
																	The Colorado Department of Revenue reported 673 cannabis dispensaries by the end of August, with an average revenue of $162,000...
 
																	Removing 280E in 2025 could drastically improve cash flow for cannabis companies. See how major MSOs like Green Thumb, Trulieve...
 
																	Viridian Capital Advisors provides cannabis investors with a more comprehensive EV calculation compared to traditional methods.
 
																	Benchmark analyst Mike Hickey reiterates Medicine Man Technologies (OTC:SHWZ) with a Buy and maintains $2.5 price target.
 
																	
 
																	Medicine Man Technologies (OTC:SHWZ) reported quarterly losses of $(0.20) per share which missed the analyst consensus estimate...